Expression of Soluble Form of Aurora A as a Predictive Factor for Neoadjuvant Therapy in Breast Cancer Patients: A Single-Center Pilot Study

Expression of Soluble Form of Aurora A as a Predictive Factor for Neoadjuvant Therapy in Breast Cancer Patients: A Single-Center Pilot Study

Purpose: To search for new predictive breast cancer biomarkers. We analyzed the serum concentrations of biomarkers involved in carcinogenesis, which can also be targeted by therapy. Methods: In a single-center prospective study, the serum levels of Aurora A, thymidine kinase 1, and human epidermal g...

Full description

Bibliographic Details
Main Authors: Pawel Winter, Malgorzata Fuksiewicz, Agnieszka Jagiello-Gruszfeld, Zbigniew Nowecki, Beata Kotowicz
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Cancers
Subjects:
breast cancer
neoadjuvant treatment
predictive marker
AURKA
Aurora A
HER3
Online Access:https://www.mdpi.com/2072-6694/15/22/5446

Similar Items

Similar Items